Skip to content
GenoLensGenoLens

C1GALT1C1

Chr Xq24

C1GALT1 specific chaperone 1

Aliases:
COSMC, C1GALT2
MANE:
ENST00000304661.6

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Fetal anomalies

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Congenital disorders of glycosylation

    Other - please specify in evaluation comments
  • Likely inborn error of metabolism

    Other - please specify in evaluation comments
  • Undiagnosed metabolic disorders

    Other - please specifiy in evaluation comments

Disease associations (Open Targets)

  • hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature

    0.63
  • neurodegenerative disease

    0.46
  • carcinoma

    0.37
  • atypical hemolytic-uremic syndrome

    0.34
  • Abnormal protein O-linked glycosylation

    0.27
  • breast cancer

    0.10
  • colorectal carcinoma

    0.09
  • breast carcinoma

    0.09
  • cancer

    0.06
  • anti-neutrophil antibody associated vasculitis

    0.06

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

C1GALT1-specific chaperone 1

Probable chaperone required for the generation of 1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins. Probably acts as a specific molecular chaperone assisting the folding/stability of core 1 beta-3-galactosyltransferase (C1GALT1)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.